HOME >> BIOLOGY >> NEWS
Popular Science outlines need for long-term studies and more regulation in A.R.T.

America Online to Carry Article Exclusively and Will Host Online Chat on Tuesday, February 11 at 8pm EST

New York, NY, February 6, 2003 -- In an article in its March issue (on newsstands February 11), Popular Science magazine describes the need for long-term studies and more regulation in assisted reproductive technology (ART). The article "Sallie has 2 Mommies & 1 Daddy," explores the science behind the risks of ART and the problems with the U.S. regulatory system that have allowed untested technologies to be used on patients for decades without oversight.

One in 11 couples in the United States is infertile. Desperation to have a child is widespread. Each year, thousands of these couples expose themselves and their future children to dangerous fertility treatments that were rushed from petri dishes to patients without regulation or human trials. About a million children have been born using assisted reproductive technology-otherwise known as ART-which has become so advanced, couples using it are statistically more likely to conceive a child than those relying on the old-fashioned natural approach.

The recent claim that a fringe group had cloned a human caused yet another wave of protests from scientists and politicians over reproductive cloning. It'll cause birth defects, they said, it'll create children with unimaginable problems. But with the spotlight on cloning, Americans missed one important point: For decades, fertility clinics have been doing precisely what scares experts about cloning. By using unregulated technologies on patients, they're creating children through experimental procedures with well-documented and potentially widespread risks. PopSci magazine's article examines and discusses the need for regulation and increased research into fertility methods.

The complete story can be found exclusively on AOL in the Health Channel (Keyword: Health Poll) beginning on February 6. Beginning on Monday, Feb
'"/>

Contact: Sara Delekta
sara.delekta@time4.com
917-868-4502
Popular Science
6-Feb-2003


Page: 1 2

Related biology news :

1. Popular Science announces Third Annual Brilliant 10
2. Popular Science announces second annual Brilliant 10: the countrys top young scientists
3. Popularizing precision agriculture
4. Popular weed killer feminizes native leopard frogs across Midwest
5. Popular weed killer disrupts frogs sexual development
6. Popular weed killer demasculinizes frogs, disrupts their sexual development
7. Popular pain analgesics found to affect central nervous system: Study identifies both peripheral and CNS mechanisms of action of NSAID use
8. Popular Diet Supplement May Be A Cancer Risk
9. Emu Meat Not A Popular Choice Among Consumers, Study Shows
10. New Studies Shed Light On Facial Features Of Popular Dinosaurs
11. Popular Cure-All Tea Can Cause Toxic Reactions

Post Your Comments:
(Date:4/15/2014)... LIVERMORE, Calif. Zero-emission hydrogen fuel cell systems soon could ... industrial settings at lower costs and with faster refueling ... Sandia National Laboratories and Hawaii Hydrogen Carriers (HHC). , ... solid-state hydrogen storage system that can refuel at low ... to charge a battery-powered forklift, giving hydrogen a competitive ...
(Date:4/15/2014)... research published in the March/April 2014 issue of ... shows whey protein, either as a supplement combined ... or weight-maintenance diet, may provide men and women benefits ... 14 randomized controlled trials with a total of 626 ... that used whey protein to replace calories in the ...
(Date:4/14/2014)... you,re over 24 years of age you,ve already reached ... according to a new Simon Fraser University study. ... professor Mark Blair, Thompson,s thesis supervisor, and Andrew Henrey, ... news in a just-published PLOS ONE Journal ... science experiments to rest on big data, the trio ...
Breaking Biology News(10 mins):Low-cost, hydrogen-powered forklifts with rapid refueling, zero emissions coming soon 2Low-cost, hydrogen-powered forklifts with rapid refueling, zero emissions coming soon 3Low-cost, hydrogen-powered forklifts with rapid refueling, zero emissions coming soon 4New meta-analysis builds on the power of whey protein for improved body composition 2New meta-analysis builds on the power of whey protein for improved body composition 3Study says we're over the hill at 24 2
(Date:1/15/2014)... 15, 2014 Cynvenio, a cancer diagnostics ... the genomic analysis of tumor cells in the bloodstream, ... web-based cancer decision support application powered by CollabRx, Inc. ... ClearID™ genomic test, Therapy Finder will provide breast cancer ... navigate and understand both the current standard of care ...
(Date:1/15/2014)... IPSWICH, England , January 15, 2014 ... whether technology developed to win races on the Formula ... obesity.  This unique healthcare collaboration between McLaren Applied Technologies ... academics at University Campus Suffolk is being funded by ... inspired by equipment used to collect data about the ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 DTS ... enhancement to its Online Web Portal for Life Science ... have the ability to specify the subject matter of ... 50 life science sub-domains. This will help reduce time-to-delivery ... scientific fields, and decrease the likelihood of error. , ...
(Date:1/15/2014)... 15, 2014 TaiGen Biotechnology Company, Limited ... exclusive agreement with R-Pharm, a leading Russian pharmaceutical ... ) in the Russian Federation ... members of the Commonwealth Independent States (CIS). Nemonoxacin is ... infections including those caused by drug-resistant bacteria. Under ...
Breaking Biology Technology:Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4DTS Improves Efficiency for Life Science Document Translations 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4
Cached News: